{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:53:56Z","timestamp":1791269636824,"version":"4.1.0"},"reference-count":81,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2011,1,4]],"date-time":"2011-01-04T00:00:00Z","timestamp":1294099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["chemistry-europe.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["ChemMedChem"],"published-print":{"date-parts":[[2011,2,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A series of <jats:italic>O<\/jats:italic>\u2010alkyl iminoxylitol derivatives was synthesized and evaluated as \u03b2\u2010glucocerebrosidase (GCase) inhibitors. This structure\u2013activity study shows a dramatic influence of the position of the alkyl chain (\u03b1\u2010C1, O2, O3, or O4) on human GCase inhibition. Remarkably, 1,2\u2010shift of the alkyl chain from C1 to O2 was found to maintain high inhibitory potency toward GCase as well as chaperone activity at sub\u2010inhibitory concentration (10\u2005n<jats:sc>M<\/jats:sc>). Removal of the stereogenic center at the pseudo\u2010anomeric position led to shorter and more practical synthetic sequences. 2\u2010<jats:italic>O<\/jats:italic>\u2010Alkyl iminoxylitol derivatives constitute a new promising class of leads for the treatment of Gaucher disease by means of pharmacological chaperone therapy.<\/jats:p>","DOI":"10.1002\/cmdc.201000469","type":"journal-article","created":{"date-parts":[[2011,1,4]],"date-time":"2011-01-04T11:40:07Z","timestamp":1294141207000},"page":"353-361","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Second\u2010Generation Iminoxylitol\u2010Based Pharmacological Chaperones for the Treatment of Gaucher Disease"],"prefix":"10.1002","volume":"6","author":[{"given":"Farah","family":"Oula\u00efdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Front\u2010Deschamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Gallienne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Lesellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Compain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier R.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,1,4]]},"reference":[{"key":"e_1_2_6_1_2","unstructured":"A special issue ofPhilosophical Transactions of the Royal Society of London Series B Biological Scienceshas been devoted to the glycolipids in cell biology and medicine; see:Philos. Trans. R. Soc. Lond. B Biol. Sci.2003 358 pp.\u2005845\u2013983."},{"key":"e_1_2_6_2_2","unstructured":"\u00a0"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1042\/bst0280150"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-006-0301-4"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-3757(19990601)111:11<1632::AID-ANGE1632>3.0.CO;2-A"},{"key":"e_1_2_6_5_3","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-3773(19990601)38:11<1532::AID-ANIE1532>3.0.CO;2-U"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.60.070191.001353"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2006.05.027"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1023\/B:GLYC.0000046272.38480.ef"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/ange.200902620"},{"key":"e_1_2_6_9_3","doi-asserted-by":"publisher","DOI":"10.1002\/anie.200902620"},{"key":"e_1_2_6_10_2","unstructured":"\u00a0"},{"key":"e_1_2_6_11_2","volume-title":"Gaucher\u2019s Disease","author":"Zimran A.","year":"1997"},{"key":"e_1_2_6_12_2","first-page":"3635","volume-title":"The Metabolic and Molecular Basis of Inherited Diseases","author":"Beutler E.","year":"2001"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2007.05.035"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.1380030102"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/9780470517437.ch11"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2003.1273"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-006-0280-4"},{"key":"e_1_2_6_18_2","unstructured":"\u00a0"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2004.01.004"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwi076"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2008.00653.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-006-0239-6"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2006.01.010"},{"key":"e_1_2_6_24_2","unstructured":"\u00a0"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1021\/cr990292q"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.2174\/1568026033452483"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.10.3.455"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2003.1279"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2008.00656.x"},{"key":"e_1_2_6_30_2","unstructured":"\u00a0"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02161-9"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1023\/B:BOLI.0000045756.54006.17"},{"key":"e_1_2_6_33_2","unstructured":"\u00a0"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/9780470517437.ch10"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(03)00158-5"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1515\/BC.2008.009"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2007.06042.x"},{"key":"e_1_2_6_38_2","unstructured":"\u00a0"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.04-2375com"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.200800249"},{"key":"e_1_2_6_41_2","unstructured":"For selected efforts directed toward the development of pharmacological chaperones against Gaucher disease see:"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2004.03.007"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2005.04.023"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/ange.200502662"},{"key":"e_1_2_6_44_3","doi-asserted-by":"publisher","DOI":"10.1002\/anie.200502662"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm060677i"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2006.05410.x"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm801506m"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.200900442"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.200700061"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2008.06.026"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.192582899"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0705637104"},{"key":"e_1_2_6_53_2","unstructured":"\u00a0"},{"key":"e_1_2_6_54_2","volume-title":"Iminosugars as Glycosidase Inhibitors: Nojirimycin and Beyond","year":"1999"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/9780470517437"},{"key":"e_1_2_6_56_2","unstructured":"\u00a0"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tetasy.2005.03.015"},{"key":"e_1_2_6_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2006.08.003"},{"key":"e_1_2_6_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.carres.2007.03.015"},{"key":"e_1_2_6_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2010.02.027"},{"key":"e_1_2_6_61_2","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.200600217"},{"key":"e_1_2_6_62_2","doi-asserted-by":"publisher","DOI":"10.1021\/jo035763u"},{"key":"e_1_2_6_63_2","doi-asserted-by":"publisher","DOI":"10.1021\/ol035117h"},{"key":"e_1_2_6_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2004.09.086"},{"key":"e_1_2_6_65_2","unstructured":"\u03b1\u20101\u2010C\u2010Nonylimino\u2010D\u2010xylitol (3) was obtained in 10 steps and 6\u2009% overall yield fromL\u2010xylose (see Ref.\u2005[19])."},{"key":"e_1_2_6_66_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj20030348"},{"key":"e_1_2_6_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6215(00)81480-9"},{"key":"e_1_2_6_68_2","doi-asserted-by":"publisher","DOI":"10.1021\/jo01052a076"},{"key":"e_1_2_6_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6215(00)80483-8"},{"key":"e_1_2_6_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0040-4039(00)79279-3"},{"key":"e_1_2_6_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2004.07.039"},{"key":"e_1_2_6_72_2","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.35.2894"},{"key":"e_1_2_6_73_2","doi-asserted-by":"publisher","DOI":"10.1021\/cc010078r"},{"key":"e_1_2_6_74_2","doi-asserted-by":"publisher","DOI":"10.3891\/acta.chem.scand.08-0251"},{"key":"e_1_2_6_75_2","doi-asserted-by":"publisher","DOI":"10.1021\/jo016221k"},{"key":"e_1_2_6_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0957-4166(02)00752-8"},{"key":"e_1_2_6_77_2","unstructured":"F. Oula\u00efdi P. Compain K. Ikeda N. Asano E. Gallienne O.\u2005R. Martin et\u2005al.unpublished results."},{"key":"e_1_2_6_78_2","unstructured":"IC50forN\u2010nonyl\u2010DIX=1500\u2005nM.[19]Estimated IC50value forN\u2010hexyl\u2010DIX is therefore >1500\u2005nM."}],"container-title":["ChemMedChem"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcmdc.201000469","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/chemistry-europe.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cmdc.201000469","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T09:17:51Z","timestamp":1760260671000},"score":1,"resource":{"primary":{"URL":"https:\/\/chemistry-europe.onlinelibrary.wiley.com\/doi\/10.1002\/cmdc.201000469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,4]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2,7]]}},"alternative-id":["10.1002\/cmdc.201000469"],"URL":"https:\/\/doi.org\/10.1002\/cmdc.201000469","archive":["Portico"],"relation":{},"ISSN":["1860-7179","1860-7187"],"issn-type":[{"value":"1860-7179","type":"print"},{"value":"1860-7187","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,4]]},"assertion":[{"value":"2010-10-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-01-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}